b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30605780</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>03</Month>\n            <Day>25</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>03</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1873-6971</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>133</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Fitoterapia</Title>\n                <ISOAbbreviation>Fitoterapia</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Gossypol inhibits 5\xce\xb1-reductase 1 and 3\xce\xb1-hydroxysteroid dehydrogenase: Its possible use for the treatment of prostate cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>102-108</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0367-326X(18)32142-7</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fitote.2018.12.024</ELocationID>\n            <Abstract>\n                <AbstractText>Gossypol is a yellow polyphenol isolated from cotton seeds. It has the antitumor activity and it is being tested to treat prostate cancer. However, its underlying mechanisms are still not well understood. The present study investigated the inhibitory effects of gossypol acetate on rat 5\xce\xb1-reductase 1, 3\xce\xb1-hydroxysteroid dehydrogenase, and retinol dehydrogenase 2 for androgen metabolism. Rat 5\xce\xb1-reductase 1, 3\xce\xb1-hydroxysteroid dehydrogenase, and retinol dehydrogenase 2 were expressed in COS-1 cells. Immature Leydig cells that contain these enzymes were isolated from 35-day-old male Sprague Dawley rats. The potency and mode of action of gossypol acetate to inhibit these enzymes in both enzyme-expressed preparations and immature Leydig cells were examined. Molecular docking study of gossypol on the crystal structure of 3\xce\xb1-hydroxysteroid dehydrogenase was performed. Gossypol acetate inhibited 5\xce\xb1-reductase 1 and 3\xce\xb1-hydroxysteroid dehydrogenase with IC<sub>50</sub> values of 3.33\xe2\x80\xaf\xc2\xb1\xe2\x80\xaf0.07 and 0.52\xe2\x80\xaf\xc2\xb1\xe2\x80\xaf0.06\xe2\x80\xaf\xc3\x97\xe2\x80\xaf10<sup>-6</sup>\xe2\x80\xafM in the expressed enzymes as well as 8.512\xe2\x80\xaf\xc2\xb1\xe2\x80\xaf0.079 and 1.032\xe2\x80\xaf\xc2\xb1\xe2\x80\xaf0.068\xe2\x80\xaf\xc3\x97\xe2\x80\xaf10<sup>-6</sup>\xe2\x80\xafM in intact rat immature Leydig cells, respectively. Gossypol acetate inhibited rat 5\xce\xb1-reductase 1 in a noncompetitive mode and 3\xce\xb1-hydroxysteroid dehydrogenase in a mixed mode when steroid substrates were supplied. Gossypol acetate weakly inhibited retinol dehydrogenase 2 with IC<sub>50</sub> value over 1\xe2\x80\xaf\xc3\x97\xe2\x80\xaf10<sup>-4</sup>\xe2\x80\xafM. Molecular docking analysis showed that gossypol partially bound to the steroid-binding site of the crystal structure of rat 3\xce\xb1-hydroxysteroid dehydrogenase. Gossypol acetate is a potent inhibitor of rat 5\xce\xb1-reductase 1 and 3\xce\xb1-hydroxysteroid dehydrogenase, possibly inhibiting the formation of androgen in the prostate cancer cells.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Cao</LastName>\n                    <ForeName>Shuyan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, China; Center of Scientific Research, The Second Affiliated Hospital and Yuying Children\'s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Guimin</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children\'s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ge</LastName>\n                    <ForeName>Fei</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital and Yuying Children\'s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Li</LastName>\n                    <ForeName>Xiaoheng</ForeName>\n                    <Initials>X</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center of Scientific Research, The Second Affiliated Hospital and Yuying Children\'s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhu</LastName>\n                    <ForeName>Qiqi</ForeName>\n                    <Initials>Q</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center of Scientific Research, The Second Affiliated Hospital and Yuying Children\'s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ge</LastName>\n                    <ForeName>Ren-Shan</ForeName>\n                    <Initials>RS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center of Scientific Research, The Second Affiliated Hospital and Yuying Children\'s Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Electronic address: r_ge@yahoo.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Yunshan</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, China. Electronic address: sdjnwys@163.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>31</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>Fitoterapia</MedlineTA>\n            <NlmUniqueID>16930290R</NlmUniqueID>\n            <ISSNLinking>0367-326X</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D058891">5-alpha Reductase Inhibitors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.1.-</RegistryNumber>\n                <NameOfSubstance UI="D000429">Alcohol Oxidoreductases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.1.-</RegistryNumber>\n                <NameOfSubstance UI="D006913">Hydroxysteroid Dehydrogenases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.1.1.105</RegistryNumber>\n                <NameOfSubstance UI="C022520">retinol dehydrogenase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>KAV15B369O</RegistryNumber>\n                <NameOfSubstance UI="D006072">Gossypol</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>S7RL72610R</RegistryNumber>\n                <NameOfSubstance UI="C028178">gossypol acetic acid</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D058891" MajorTopicYN="N">5-alpha Reductase Inhibitors</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000429" MajorTopicYN="N">Alcohol Oxidoreductases</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006072" MajorTopicYN="N">Gossypol</DescriptorName>\n                <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006913" MajorTopicYN="N">Hydroxysteroid Dehydrogenases</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007985" MajorTopicYN="N">Leydig Cells</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>\n                <QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">3\xce\xb1-hydroxysteroid dehydrogenase</Keyword>\n            <Keyword MajorTopicYN="N">5\xce\xb1-reductase 1</Keyword>\n            <Keyword MajorTopicYN="N">Gossypol</Keyword>\n            <Keyword MajorTopicYN="N">Mode of action</Keyword>\n            <Keyword MajorTopicYN="N">Retinol dehydrogenase 2</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>28</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>12</Month>\n                <Day>29</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>26</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>1</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30605780</ArticleId>\n            <ArticleId IdType="pii">S0367-326X(18)32142-7</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.fitote.2018.12.024</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'